<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Pain Res</journal-id><journal-id journal-id-type="iso-abbrev">J Pain Res</journal-id><journal-id journal-id-type="publisher-id">Journal of Pain Research</journal-id><journal-title-group><journal-title>Journal of Pain Research</journal-title></journal-title-group><issn pub-type="epub">1178-7090</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27703393</article-id><article-id pub-id-type="pmc">5036542</article-id><article-id pub-id-type="doi">10.2147/JPR.S109616</article-id><article-id pub-id-type="publisher-id">jpr-9-689</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Effectiveness of low-dose intravenous ketamine to attenuate stress response in patients undergoing emergency cesarean section with spinal anesthesia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Senapathi</surname><given-names>Tjokorda Gde Agung</given-names></name><xref ref-type="aff" rid="af1-jpr-9-689"/><xref ref-type="corresp" rid="c1-jpr-9-689"/></contrib><contrib contrib-type="author"><name><surname>Widnyana</surname><given-names>I Made Gede</given-names></name><xref ref-type="aff" rid="af1-jpr-9-689"/></contrib><contrib contrib-type="author"><name><surname>Wiryana</surname><given-names>Made</given-names></name><xref ref-type="aff" rid="af1-jpr-9-689"/></contrib><contrib contrib-type="author"><name><surname>Aribawa</surname><given-names>I Gusti Ngurah Mahaalit</given-names></name><xref ref-type="aff" rid="af1-jpr-9-689"/></contrib><contrib contrib-type="author"><name><surname>Aryabiantara</surname><given-names>I Wayan</given-names></name><xref ref-type="aff" rid="af1-jpr-9-689"/></contrib><contrib contrib-type="author"><name><surname>Hartawan</surname><given-names>I Gusti Agung Gede Utara</given-names></name><xref ref-type="aff" rid="af1-jpr-9-689"/></contrib><contrib contrib-type="author"><name><surname>Sinardja</surname><given-names>I Ketut</given-names></name><xref ref-type="aff" rid="af1-jpr-9-689"/></contrib><contrib contrib-type="author"><name><surname>Suarjaya</surname><given-names>I Putu Pramana</given-names></name><xref ref-type="aff" rid="af1-jpr-9-689"/></contrib><contrib contrib-type="author"><name><surname>Nada</surname><given-names>I Ketut Wibawa</given-names></name><xref ref-type="aff" rid="af1-jpr-9-689"/></contrib><contrib contrib-type="author"><name><surname>Jaya</surname><given-names>AA Gde Putra Semara</given-names></name><xref ref-type="aff" rid="af1-jpr-9-689"/></contrib></contrib-group><aff id="af1-jpr-9-689">Department of Anesthesiology and Intensive Care, Faculty of Medicine, Udayana University, Sanglah Hospital, Bali, Indonesia</aff><author-notes><corresp id="c1-jpr-9-689">Correspondence: Tjokorda Gde Agung Senapathi, Department of Anesthesiology and Intensive Care, Faculty of Medicine, Udayana University, Sanglah Hospital, Diponegoro Street, Denpasar 80114, Bali, Indonesia, Tel +62 36 1257 361, Fax +62 36 1235 980, Email <email>tjoksenapathi@unud.ac.id</email></corresp></author-notes><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>20</day><month>9</month><year>2016</year></pub-date><volume>9</volume><fpage>689</fpage><lpage>692</lpage><permissions><copyright-statement>&#x000a9; 2016 Senapathi et al. This work is published and licensed by Dove Medical Press Limited</copyright-statement><copyright-year>2016</copyright-year><license><license-p>The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution &#x02013; Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p></license></permissions><abstract><sec><title>Purpose</title><p>Cesarean section is a surgical procedure. Surgical procedures will induce stress responses, which may have negative impact on postoperative recovery. Ketamine plays a role in the homeostatic regulation of inflammatory response in order to attenuate stress response. We tried to determine the effectiveness of low-dose intravenous ketamine to attenuate stress response in patients undergoing emergency cesarean section with spinal anesthesia.</p></sec><sec><title>Patients and methods</title><p>Thirty-six pregnant women undergoing emergency cesarean section with spinal anesthesia were randomly divided into two groups (n=18). Ketamine 0.3 mg/kg (KET group) or NaCl 0.9% (NS group) was administered intravenously before the administration of spinal anesthesia. C-reactive protein (CRP) and neutrophil levels were measured preoperatively and postoperatively.</p></sec><sec><title>Results</title><p>Elevation of CRP stress response was lower in the KET group and significantly different (<italic>P</italic>&#x02264;0.05) from that in the NS group. Neutrophil level was elevated in both the groups and hence not significantly different from each other (<italic>P</italic>&#x0003e;0.05). Postoperative visual analog scale pain score was not significantly different between the two groups (<italic>P</italic>&#x0003e;0.05), but there was a statistically significant (<italic>P</italic>&#x02264;0.05) positive and weak correlation between visual analog scale and CRP level postoperatively.</p></sec><sec><title>Conclusion</title><p>Low-dose intravenous ketamine effectively attenuates the CRP stress response in patients undergoing emergency cesarean section with spinal anesthesia.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>ketamine</kwd><kwd>stress response</kwd><kwd>pain</kwd><kwd>spinal anesthesia</kwd><kwd>cesarean section</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Cesarean section evokes stress response, which is associated with postoperative morbidity. Regional anesthesia can suppress neuroendocrine response but cannot suppress cytokine response.<xref rid="b1-jpr-9-689" ref-type="bibr">1</xref> Interleukin (IL)-6 is a major cytokine responsible for inducing acute-phase response. One of the acute-phase responses is the production of acute-phase proteins by the liver (eg, C-reactive protein [CRP]).<xref rid="b2-jpr-9-689" ref-type="bibr">2</xref>,<xref rid="b3-jpr-9-689" ref-type="bibr">3</xref> Elevation of CRP serum level will be affected by IL-6 level. Stress response is also characterized by an increase in the number of neutrophils that will undergo diapedesis to inflammation site through the vascular endothelium.<xref rid="b4-jpr-9-689" ref-type="bibr">4</xref> In addition to tissue injury, postoperative pain can aggravate stress response.<xref rid="b1-jpr-9-689" ref-type="bibr">1</xref></p><p>Ketamine is the drug of choice for induction of general anesthesia in patients undergoing a cesarean section. Ketamine results in less fetal depression. Ketamine has a rapid onset and short duration of action as well as provides analgesia and hypnosis of better quality. Ketamine is also an option in cases of severe fetal distress.<xref rid="b5-jpr-9-689" ref-type="bibr">5</xref>,<xref rid="b9-jpr-9-689" ref-type="bibr">9</xref>&#x02013;<xref rid="b11-jpr-9-689" ref-type="bibr">11</xref></p><p>Loix et al in their systematic review concluded that ketamine at a very low dose (0.25 mg/kg) may inhibit exacerbations of inflamation.<xref rid="b5-jpr-9-689" ref-type="bibr">5</xref> Similarly, Dale et al in a systematic study and meta-analysis concluded that intraoperative ketamine significantly inhibited IL-6 postoperative stress response.<xref rid="b6-jpr-9-689" ref-type="bibr">6</xref></p><p>Through this research, we tried to determine the effectiveness of low-dose intravenous ketamine 0.3 mg/kg in attenuating postoperative stress response, especially in patients undergoing emergency cesarean section.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec sec-type="subjects"><title>Patients</title><p>This is an experimental study with a double-blind randomized controlled trial design. A total of 36 pregnant women undergoing emergency cesarean section with spinal anesthesia in the emergency operating room at Sanglah Hospital (Joint Commission International &#x02013; Accredited) from December 2015 to February 2016 were enrolled in the study (consecutive sampling). Patients were not enrolled in the study if any the following criteria were present: patient refusal, physical status ASA III or more, body mass index before pregnancy less than 18.5 or more than 24.9 kg/m<sup>2</sup>, hypertension during pregnancy, a history of chronic analgesic use, a history of coronary heart disease and stroke, and contraindications using ketamine or midazolam. The subjects were assigned into two groups by permuted-block randomization. The subject will be issued when such condition occur: bleeding more than 1,000 mL, changes in anesthetic techniques, and discharge against medical advice before 24 hours postoperatively. There is no loss of subject in this study.</p></sec><sec sec-type="methods"><title>Procedures</title><p>In the preparation room of emergency operating theater, basal blood pressure and heart rate of the subjects were measured, intravenous access was obtained, blood samples for preoperative CRP and neutrophil were collected, and ringer lactate 10 mL/kg and midazolam 0.03 mg/kg were administered intravenously. In the operating room, the subjects received oxygen supplementation of 2 L/min through a nasal cannula. Three milliliters of ketamine 0.3 mg/kg (KET group) or 0.9% NaCl (NS group) was administered within 30 seconds at the disinfection step of spinal anesthesia. Spinal anesthesia was performed with Quincke type needle G27 using 0.5% hyperbaric bupivacaine 12.5 mg at the rate of 0.2 mL/sec. Pin-prick test was performed to assess the height of the block based on skin dermatome. Apgar scores of newborns were evaluated. Postoperative patients received fentanyl 0.25 &#x000b5;/kg/h and ketorolac 30 mg every 8 hours intravenously as analgesia. Postoperative CRP, neutrophil, and visual analog scale (VAS) were measured after 24 hours.</p></sec><sec sec-type="methods"><title>Statistical analysis</title><p>Data analysis was done using Statistical Package for Social Sciences for Windows (IBM Corporation, Armonk, NY) software version 20. Numerical variables were expressed as mean &#x000b1; standard or median (minimum&#x02013;maximum). Test for normality was performed using Shapiro&#x02013;Wilk test and homogeneity test using Levene&#x02019;s test. Mean tests were compared using independent <italic>t</italic>-test if data distribution was normal or using nonparametric Mann&#x02013;Whitney <italic>U</italic> test if data were not distributed normally. The level of significance was <italic>a</italic>=0.05.</p></sec><sec><title>Ethics statements</title><p>This study was approved by the Research Ethics Committee of Faculty of Medicine, Udayana University, Sanglah Hospital (1852/UN.14.2/Litbang/2015). Written informed consent was obtained from all the subjects.</p></sec></sec><sec sec-type="results"><title>Results</title><p>As shown in <xref ref-type="table" rid="t1-jpr-9-689">Table 1</xref>, subject characteristics (age, body mass index, and duration of surgery) were not significantly different in the two groups (<italic>P</italic>&#x0003e;0.05). <xref ref-type="table" rid="t2-jpr-9-689">Table 2</xref> presents the perioperative CRP levels. Preoperative CRP levels were not significantly different in the two groups (<italic>P</italic>&#x0003e;0.05), with a median of 4.7 mg/L in the KET group and 3.7 mg/L in the NS group. There were significant differences in postoperative CRP levels in both the groups (<italic>P</italic>&#x02264;0.05), with a mean of 32.3&#x000b1;29.7 mg/L in the KET group and 72.1&#x000b1;54.4 mg/L in the NS group. Statistical analysis of the elevation of CRP resulted in median value of 4.7 times in the KET group and 8.6 times in the NS group, with significant difference (<italic>P</italic>&#x02264;0.05). Neutrophil level was not significantly different for preoperative and postoperative levels as well as for the elevation. <xref ref-type="table" rid="t3-jpr-9-689">Table 3</xref> shows a mean preoperative neutrophil level of 9.6&#x000b1;4.4 10<sup>3</sup>/&#x000b5;L in the KET group and 9.08&#x000b1;3 10<sup>3</sup>/&#x000b5;L in the NS group, with <italic>P</italic>&#x0003e;0.05. The increase in neutrophil level in both the groups did not differ significantly.</p><p>As shown in <xref ref-type="table" rid="t4-jpr-9-689">Table 4</xref>, postoperative pain scores did not differ significantly in both the groups (<italic>P</italic>&#x0003e;0.05). The mean VAS for the KET group was 1.6&#x000b1;0.8 and 1.9&#x000b1;1.2 for the NS group. The maximum VAS value was 3 cm in the KET group and 4 cm in the NS group.</p><p>Based on Spearman test between postoperative VAS value and postoperative CRP level (<xref ref-type="table" rid="t5-jpr-9-689">Table 5</xref>), there was a weak positive correlation with a correlation coefficient of 0.374, which was statistically significant (<italic>P</italic>&#x02264;0.05). <xref ref-type="table" rid="t6-jpr-9-689">Table 6</xref> presents the Apgar score. Apgar scores of 1 and 5 minutes in both the groups were not significantly different with <italic>P</italic>&#x0003e;0.05.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>Surgery or trauma will evoke a stress response. Stress response is a physiological response that arises to protect the body from injury and to survive. There is growing evidence that there is a stress response associated with postoperative morbidity. Neuroendocrine response stimulated by pain stimulus afferent fibers to the central nervous system can be reduced or eliminated through a regional nerve block anesthesia. Cytokine responses that are stimulated by local tissue damage at the site of surgery cannot be inhibited by regional anesthesia.<xref rid="b1-jpr-9-689" ref-type="bibr">1</xref>,<xref rid="b8-jpr-9-689" ref-type="bibr">8</xref></p><p>Cytokine response begins with the release of IL-1 and tumor necrosis factor-<italic>a</italic> on the activation of macrophages and monocytes from the damaged tissue. This will stimulate the production and release of other cytokines, particularly IL-6 as it is the major cytokine responsible for the systemic change known as the acute-phase response. Acute-phase protein (ie, CRP, fibrinogen, <italic>a</italic><sub>2</sub>-macroglobulin) produced by the liver. This protein acts as mediator of inflammation, anti-proteinase, and scavengers, and affect tissue repair. Elevation of CRP serum level will be affected by IL-6 levels.<xref rid="b2-jpr-9-689" ref-type="bibr">2</xref></p><p>Injury to nerve tissues in the skin layer can cause severe pain due to peripheral and central sensitization. Peripheral sensitization occurs due to the release of local inflammatory mediators. Central sensitization occurs due to recurrent pain stimulation. Pain will aggravate stress response.<xref rid="b1-jpr-9-689" ref-type="bibr">1</xref>,<xref rid="b12-jpr-9-689" ref-type="bibr">12</xref></p><p>Cytokine response can be suppressed by the administration of ketamine. According to a review by Golubovskiy and Vanags, the addition of a low dose of ketamine before the induction of general anesthesia produces a decrease in the secretion of proinflammatory cytokines IL-6 and tumor necrosis factor-<italic>a</italic>, as well as maintains the production of IL-2.<xref rid="b7-jpr-9-689" ref-type="bibr">7</xref> In a review of ketamine and peripheral inflammation, De Kock et al summarized that ketamine acts as a homeostatic regulator of acute inflammatory reactions and stress-induced immune disturbances.<xref rid="b8-jpr-9-689" ref-type="bibr">8</xref> Ketamine prevents the exacerbations and extension of local inflammation, without blunting local process and delaying the resolution of inflammation. In vitro studies have clearly shown that ketamine can significantly reduce the number of proinflammatory cytokines without affecting the production of anti-inflammatory cytokines. Ketamine reduces the expression of adhesion molecules on the surface of immune cells, thereby limiting diapedesis of neutrophils to inflammation sites and attenuating increased production of superoxide anions by neutrophils.<xref rid="b5-jpr-9-689" ref-type="bibr">5</xref>,<xref rid="b8-jpr-9-689" ref-type="bibr">8</xref>,<xref rid="b14-jpr-9-689" ref-type="bibr">14</xref> The regulatory role of ketamine is more pronounced when administered before the injury.<xref rid="b8-jpr-9-689" ref-type="bibr">8</xref></p><p>Ketamine provides powerful analgesic effects, which last until postoperative period.<xref rid="b10-jpr-9-689" ref-type="bibr">10</xref> There is growing evidence that low-dose ketamine plays an important role in improving the management of postoperative pain when used as an adjuvant opioid or a local anesthesia.<xref rid="b7-jpr-9-689" ref-type="bibr">7</xref> In a study by Hassan, it was concluded that low-dose intravenous ketamine prior to spinal anesthesia, showed some preventive or preemptive analgesic properties, prolonging spinal block, delaying the onset of pain, reducing the need for analgesia, and resulted in lower pain scores in the early few hours (up to 8 hours) postoperatively. Analgesic properties of ketamine are achieved through inhibition of N-methyl-D-aspartate receptors.</p><p>Ketamine attenuates postoperative CRP level through several mechanisms. Elevated CRP level reflects stress response or inflammation reaction. CRP is one of the acute-phase proteins produced by the liver, which is involved in acute-phase response. Elevation of CRP serum level will be affected by IL-6 level (a proinflammatory cytokine).</p></sec><sec><title>Conclusion</title><p>Low-dose intravenous ketamine effectively attenuates CRP stress response in patients undergoing emergency cesarean section with spinal anesthesia. Pain scores did not differ significantly in both the groups. There was a weak positive correlation between postoperative VAS score of pain and CRP level, which was statistically significant. Low-dose intravenous ketamine does not affect the Apgar scores of newborns.</p></sec></body><back><fn-group><fn><p><bold>Disclosure</bold></p><p>The authors report no conflicts of interest in this work.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-jpr-9-689"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Deakin</surname><given-names>CD</given-names></name></person-group><article-title>Metabolism, the stress response to surgery and perioperative thermoregulation</article-title><person-group person-group-type="editor"><name><surname>Aitkenhead</surname><given-names>AR</given-names></name><name><surname>Moppett</surname><given-names>IK</given-names></name><name><surname>Thompson</surname><given-names>JP</given-names></name></person-group><source>Smith &#x00026; Aitkenhead&#x02019;s Textbook of Anaesthesia</source><edition>6th ed</edition><publisher-loc>China</publisher-loc><publisher-name>Elsevier</publisher-name><year>2013</year><fpage>180</fpage><lpage>198</lpage></element-citation></ref><ref id="b2-jpr-9-689"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desborough</surname><given-names>JP</given-names></name></person-group><article-title>The stress response to trauma and surgery</article-title><source>Br J Anaesth</source><year>2000</year><volume>85</volume><issue>1</issue><fpage>109</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">10927999</pub-id></element-citation></ref><ref id="b3-jpr-9-689"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burton</surname><given-names>D</given-names></name><name><surname>Nicholson</surname><given-names>G</given-names></name><name><surname>Hall</surname><given-names>G</given-names></name></person-group><article-title>Endocrine and metabolic response to surgery</article-title><source>Continuing Ed Anaesthesia Crit Care Pain</source><year>2004</year><volume>4</volume><issue>5</issue><fpage>144</fpage><lpage>147</lpage></element-citation></ref><ref id="b4-jpr-9-689"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>DS</given-names></name><name><surname>Watts</surname><given-names>A</given-names></name><name><surname>Scott-Coombes</surname><given-names>D</given-names></name><name><surname>Avades</surname><given-names>T</given-names></name></person-group><article-title>Clinical utility of perioperative C-reactive protein testing in general surgery</article-title><source>Ann R Coll Surg Engl</source><year>2008</year><volume>90</volume><issue>4</issue><fpage>317</fpage><lpage>321</lpage><pub-id pub-id-type="pmid">18492397</pub-id></element-citation></ref><ref id="b5-jpr-9-689"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loix</surname><given-names>S</given-names></name><name><surname>De Kock</surname><given-names>M</given-names></name><name><surname>Henin</surname><given-names>P</given-names></name></person-group><article-title>The anti-inflammatory effects of ketamine: state of the art</article-title><source>Acta Anaesthesiol Belg</source><year>2011</year><volume>62</volume><issue>1</issue><fpage>47</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">21612145</pub-id></element-citation></ref><ref id="b6-jpr-9-689"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dale</surname><given-names>O</given-names></name><name><surname>Somogyi</surname><given-names>AA</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Sullivan</surname><given-names>T</given-names></name><name><surname>Shavit</surname><given-names>Y</given-names></name></person-group><article-title>Does intraoperative ketamine attenuate inflammatory reactivity following surgery? A systematic review and meta-analysis</article-title><source>Anesth Analg</source><year>2012</year><volume>115</volume><issue>4</issue><fpage>934</fpage><lpage>943</lpage><pub-id pub-id-type="pmid">22826531</pub-id></element-citation></ref><ref id="b7-jpr-9-689"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golubovska</surname><given-names>I</given-names></name><name><surname>Vanags</surname><given-names>I</given-names></name></person-group><article-title>Anaesthesia and stress response to surgery</article-title><source>Proc Latv Acad Sci</source><year>2008</year><volume>62</volume><issue>5</issue><fpage>141</fpage><lpage>147</lpage></element-citation></ref><ref id="b8-jpr-9-689"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Kock</surname><given-names>M</given-names></name><name><surname>Loix</surname><given-names>S</given-names></name><name><surname>Lavand&#x02019;homme</surname><given-names>P</given-names></name></person-group><article-title>Ketamine and peripheral inflammation</article-title><source>CNS Neurosci Ther</source><year>2013</year><volume>19</volume><issue>6</issue><fpage>403</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">23574634</pub-id></element-citation></ref><ref id="b9-jpr-9-689"><label>9</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kuczkowski</surname><given-names>KM</given-names></name><name><surname>Reisner</surname><given-names>LS</given-names></name><name><surname>Lin</surname><given-names>D</given-names></name></person-group><article-title>Anesthesia for cesarean section</article-title><person-group person-group-type="editor"><name><surname>Chestnut</surname><given-names>DH</given-names></name></person-group><source>Obstetric Anesthesia: Principles and Practice</source><edition>5th ed</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Mosby</publisher-name><year>2014</year><fpage>545</fpage><lpage>603</lpage></element-citation></ref><ref id="b10-jpr-9-689"><label>10</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dershwitz</surname><given-names>M</given-names></name><name><surname>Rosow</surname><given-names>CE</given-names></name></person-group><article-title>Pharmacology of intravenous anesthetics</article-title><person-group person-group-type="editor"><name><surname>Longnecker</surname><given-names>DE</given-names></name><name><surname>Brown</surname><given-names>DL</given-names></name><name><surname>Newman</surname><given-names>MF</given-names></name><name><surname>Zapol</surname><given-names>WM</given-names></name></person-group><source>Anesthesiology</source><edition>2nd ed</edition><publisher-loc>New York</publisher-loc><publisher-name>McGraw-Hill</publisher-name><year>2012</year><fpage>687</fpage><lpage>702</lpage></element-citation></ref><ref id="b11-jpr-9-689"><label>11</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rathmell</surname><given-names>JP</given-names></name><name><surname>Rosow</surname><given-names>CE</given-names></name></person-group><article-title>Intravenous sedatives and hypnotics</article-title><person-group person-group-type="editor"><name><surname>Flood</surname><given-names>P</given-names></name><name><surname>Rathmell</surname><given-names>JP</given-names></name><name><surname>Shafer</surname><given-names>S</given-names></name></person-group><source>Stoelting&#x02019;s Pharmacology &#x00026; Physiology in Anesthetic Practice</source><edition>5th ed</edition><publisher-loc>Illinois</publisher-loc><publisher-name>Wolters Kluwer Health</publisher-name><year>2015</year></element-citation></ref><ref id="b12-jpr-9-689"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>M</given-names></name></person-group><article-title>Stress response and anaesthesia. Altering the peri and postoperative management</article-title><source>Indian J Anaesth</source><year>2013</year><volume>47</volume><issue>6</issue><fpage>427</fpage><lpage>434</lpage></element-citation></ref><ref id="b13-jpr-9-689"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>AA</given-names></name></person-group><article-title>Pre-emptive analgesic effect of low dose N-methyl-D-aspartate receptor antagonists: ketamine and magnesium in conjunction with spinal anesthesia</article-title><source>Alexandria J Anaesth Intensive Care</source><year>2006</year><volume>9</volume><fpage>18</fpage><lpage>25</lpage></element-citation></ref><ref id="b14-jpr-9-689"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zilberstein</surname><given-names>G</given-names></name><name><surname>Levy</surname><given-names>R</given-names></name><name><surname>Rachinsky</surname><given-names>M</given-names></name><etal/></person-group><article-title>Ketamine attenuates neutrophil activation after cardiopulmonary bypass</article-title><source>Anesth Analg</source><year>2002</year><volume>95</volume><fpage>531</fpage><lpage>536</lpage><pub-id pub-id-type="pmid">12198030</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="t1-jpr-9-689" position="float"><label>Table 1</label><caption><p>Subject characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="top" align="left" colspan="1">Characteristics</th><th colspan="2" valign="top" align="left" rowspan="1">Groups
<hr/></th><th rowspan="2" valign="top" align="left" colspan="1"><italic>P</italic>-value</th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">KET (n=18)</th><th valign="top" align="left" rowspan="1" colspan="1">NS (n=18)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age (years)</td><td valign="top" align="left" rowspan="1" colspan="1">28.9&#x000b1;6.2</td><td valign="top" align="left" rowspan="1" colspan="1">29.7&#x000b1;5.9</td><td valign="top" align="left" rowspan="1" colspan="1">0.702<xref ref-type="table-fn" rid="tfn2-jpr-9-689">*</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td valign="top" align="left" rowspan="1" colspan="1">20.6 (18.5&#x02013;24.5)</td><td valign="top" align="left" rowspan="1" colspan="1">23.9 (18.8&#x02013;24.9)</td><td valign="top" align="left" rowspan="1" colspan="1">0.059<xref ref-type="table-fn" rid="tfn3-jpr-9-689">#</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Duration of surgery (minutes)</td><td valign="top" align="left" rowspan="1" colspan="1">62.2&#x000b1;12.4</td><td valign="top" align="left" rowspan="1" colspan="1">68.3&#x000b1;8.1</td><td valign="top" align="left" rowspan="1" colspan="1">0.088<xref ref-type="table-fn" rid="tfn2-jpr-9-689">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="tfn1-jpr-9-689"><p><bold>Notes:</bold> Values are expressed as mean &#x000b1; SD and median (minimum&#x02013;maximum);</p></fn><fn id="tfn2-jpr-9-689"><label>*</label><p>independent <italic>t</italic>-test,</p></fn><fn id="tfn3-jpr-9-689"><label>#</label><p>Mann&#x02013;Whitney <italic>U</italic> test.</p></fn><fn id="tfn4-jpr-9-689"><p><bold>Abbreviations:</bold> KET, ketamine 0.3 mg/kg; n, number of subjects; NS, NaCl 0.9%; BMI, body mass index; SD, standard deviation.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-jpr-9-689" position="float"><label>Table 2</label><caption><p>Preoperative, postoperative, and elevation of CRP level</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="top" align="left" colspan="1">CRP</th><th colspan="2" valign="top" align="left" rowspan="1">Groups
<hr/></th><th rowspan="2" valign="top" align="left" colspan="1"><italic>P</italic>-value</th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">KET (n=18)</th><th valign="top" align="left" rowspan="1" colspan="1">NS (n=18)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Preoperative (mg/L)</td><td valign="top" align="left" rowspan="1" colspan="1">6.9&#x000b1;5.7</td><td valign="top" align="left" rowspan="1" colspan="1">6.5&#x000b1;5.2</td><td valign="top" align="left" rowspan="1" colspan="1">0.839</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">4.7 (1&#x02013;19.1)</td><td valign="top" align="left" rowspan="1" colspan="1">3.7 (1.3&#x02013;16.7)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Postoperative (mg/L)</td><td valign="top" align="left" rowspan="1" colspan="1">32.3&#x000b1;29.7</td><td valign="top" align="left" rowspan="1" colspan="1">72.1&#x000b1;54.4</td><td valign="top" align="left" rowspan="1" colspan="1">0.013</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">24.5 (0.1&#x02013;111.2)</td><td valign="top" align="left" rowspan="1" colspan="1">56.9 (0.3&#x02013;174.7)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Elevation</td><td valign="top" align="left" rowspan="1" colspan="1">7.1&#x000b1;8.1</td><td valign="top" align="left" rowspan="1" colspan="1">18.2&#x000b1;18.6</td><td valign="top" align="left" rowspan="1" colspan="1">0.029</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">4.7 (0.05&#x02013;32.5)</td><td valign="top" align="left" rowspan="1" colspan="1">8.6 (0.09&#x02013;59.6)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tfn5-jpr-9-689"><p><bold>Notes:</bold> Values are expressed as mean &#x000b1; SD and median (minimum&#x02013;maximum); Mann&#x02013;Whitney <italic>U</italic> test; elevation of CRP, CRP postoperative &#x000b8; CRP preoperative.</p></fn><fn id="tfn6-jpr-9-689"><p><bold>Abbreviations:</bold> CRP, C-reactive protein; KET, ketamine 0.3 mg/kg; n, number of subjects; NS, NaCl 0.9%; SD, standard deviation.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-jpr-9-689" position="float"><label>Table 3</label><caption><p>Preoperative, postoperative, and elevation of neutrophil level</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="top" align="left" colspan="1">Neutrophil</th><th colspan="2" valign="top" align="left" rowspan="1">Groups
<hr/></th><th rowspan="2" valign="top" align="left" colspan="1"><italic>P</italic>-value</th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">KET (n=18)</th><th valign="top" align="left" rowspan="1" colspan="1">NS (n=18)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Preoperative (10<sup>3</sup>/&#x000b5;L)</td><td valign="top" align="left" rowspan="1" colspan="1">9.6&#x000b1;4.4</td><td valign="top" align="left" rowspan="1" colspan="1">9.08&#x000b1;3</td><td valign="top" align="left" rowspan="1" colspan="1">0.664</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Postoperative (10<sup>3</sup>/&#x000b5;L)</td><td valign="top" align="left" rowspan="1" colspan="1">15.7&#x000b1;7.3</td><td valign="top" align="left" rowspan="1" colspan="1">14.8&#x000b1;5.6</td><td valign="top" align="left" rowspan="1" colspan="1">0.671</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Elevation</td><td valign="top" align="left" rowspan="1" colspan="1">2&#x000b1;1.4</td><td valign="top" align="left" rowspan="1" colspan="1">1.8&#x000b1;1</td><td valign="top" align="left" rowspan="1" colspan="1">0.509</td></tr></tbody></table><table-wrap-foot><fn id="tfn7-jpr-9-689"><p><bold>Notes:</bold> Values are expressed as mean &#x000b1; SD; independent <italic>t</italic>-test; elevation of neutrophil, neutrophil postoperative &#x000b8; neutrophil preoperative.</p></fn><fn id="tfn8-jpr-9-689"><p><bold>Abbreviations:</bold> KET, ketamine 0.3 mg/kg; n, number of subjects; NS, NaCl 0.9%; SD, standard deviation.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t4-jpr-9-689" position="float"><label>Table 4</label><caption><p>Comparison of postoperative pain score</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="top" align="left" colspan="1">VAS (cm)</th><th colspan="2" valign="top" align="left" rowspan="1">Groups
<hr/></th><th rowspan="2" valign="top" align="left" colspan="1"><italic>P</italic>-value</th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">KET (n=18)</th><th valign="top" align="left" rowspan="1" colspan="1">NS (n=18)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">24-hour postoperative</td><td valign="top" align="left" rowspan="1" colspan="1">1.6&#x000b1;0.8</td><td valign="top" align="left" rowspan="1" colspan="1">1.9&#x000b1;1.2</td><td valign="top" align="left" rowspan="1" colspan="1">0.501</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">2 (0&#x02013;3)</td><td valign="top" align="left" rowspan="1" colspan="1">2 (0&#x02013;4)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tfn9-jpr-9-689"><p><bold>Notes:</bold> Values are expressed as mean &#x000b1; SD and median (minimum&#x02013;maximum); Mann&#x02013;Whitney <italic>U</italic> test.</p></fn><fn id="tfn10-jpr-9-689"><p><bold>Abbreviations:</bold> VAS, visual analog scale; KET, ketamine 0.3 mg/kg; n, number of subjects; NS, NaCl 0.9%; SD, standard deviation.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t5-jpr-9-689" position="float"><label>Table 5</label><caption><p>Correlation between postoperative pain score and CRP level</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Postoperative</th><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="left" rowspan="1" colspan="1">CRP level</th></tr></thead><tbody><tr><td rowspan="3" valign="top" align="left" colspan="1">VAS</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic></td><td valign="top" align="left" rowspan="1" colspan="1">0.374</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic></td><td valign="top" align="left" rowspan="1" colspan="1">0.025</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>n</italic></td><td valign="top" align="left" rowspan="1" colspan="1">36</td></tr></tbody></table><table-wrap-foot><fn id="tfn11-jpr-9-689"><p><bold>Notes:</bold> Spearman test.</p></fn><fn id="tfn12-jpr-9-689"><p><bold>Abbreviations:</bold> CRP, C-reactive protein; VAS, visual analog scale; <italic>r</italic>, correlation coefficient; n, number of subjects.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t6-jpr-9-689" position="float"><label>Table 6</label><caption><p>Comparison of Apgar score of minute 1 and 5</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="top" align="left" colspan="1">Apgar score</th><th colspan="2" valign="top" align="left" rowspan="1">Groups
<hr/></th><th rowspan="2" valign="top" align="left" colspan="1"><italic>P</italic>-value</th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">KET (n=18)</th><th valign="top" align="left" rowspan="1" colspan="1">NS (n=18)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Minute 1</td><td valign="top" align="left" rowspan="1" colspan="1">6.1&#x000b1;2</td><td valign="top" align="left" rowspan="1" colspan="1">6.5&#x000b1;2.1</td><td valign="top" align="left" rowspan="1" colspan="1">0.988</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">7.5 (1&#x02013;8)</td><td valign="top" align="left" rowspan="1" colspan="1">7.5 (1&#x02013;8)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Minute 5</td><td valign="top" align="left" rowspan="1" colspan="1">8.1&#x000b1;1.5</td><td valign="top" align="left" rowspan="1" colspan="1">7.8&#x000b1;1.9</td><td valign="top" align="left" rowspan="1" colspan="1">0.767</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">8.5 (3&#x02013;9)</td><td valign="top" align="left" rowspan="1" colspan="1">8.5 (3&#x02013;9)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tfn13-jpr-9-689"><p><bold>Notes:</bold> Values are expressed as mean &#x000b1; SD and median (minimum&#x02013;maximum); Mann&#x02013;Whitney <italic>U</italic> test.</p></fn><fn id="tfn14-jpr-9-689"><p><bold>Abbreviations:</bold> KET, ketamine 0.3 mg/kg; n, number of subjects; NS, NaCl 0.9%; SD, standard deviation.</p></fn></table-wrap-foot></table-wrap></floats-group></article>